The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Open accessAbstract
Parathyroid hormone (PTH) is essential for the maintenance of calcium homeostasis through, in part, its actions to regulate bone remodeling. While PTH stimulates both bone formation and bone resorption, the duration and periodicity of exposure to PTH governs the net effect on bone mass, that is whether it is catabolic or anabolic. PTH receptor signaling in osteoblasts and osteocytes can increase the RANKL/OPG ratio, increasing both osteoclast recruitment and osteoclast activity, and thereby stimulating bone resorption. In contrast, PTH-induced bone formation is explained, at least in part, by its ability to downregulate SOST/sclerostin expression in osteocytes, permitting the anabolic Wnt signaling pathway to proceed. The two modes of administration of PTH, that is, continuous vs. intermittent, can regulate, in bone cells, different sets of genes; alternatively, the same sets of genes exposed to PTH in sustained vs. transient way, will favor bone resorption or bone formation, respectively. This article reviews the effects of PTH on bone cells that lead to these dual catabolic and anabolic actions on the skeleton.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Bilezikian, J. P., Khan, A. A., & Potts, J. T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1763 · Cited by 1,521
Self-citationMinireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Bilezikian, J. P., Brandi, M. L., Eastell, R., Silverberg, S. J., Udelsman, R., Marcocci, C., & Potts, J. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1413 · Cited by 1,271
Self-citationRomosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Self-citationIncreased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4221fje · Cited by 965
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Yadav, V. K., Ryu, J.-H., Suda, N., Tanaka, K. F., Gingrich, J. A., Schütz, G., Glorieux, F. H., Chiang, C. Y., Zajac, J. D., Insogna, K. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.059 · Cited by 834
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
Rubin, M. R., Bilezikian, J. P., McMahon, D. J., Jacobs, T., Shane, E., Siris, E., Udesky, J., & Silverberg, S. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1215 · Cited by 593
Self-citationEssential role of β-catenin in postnatal bone acquisition.
Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M.-C., Bouxsein, M. L., Deng, L., Clemens, T. L., & Williams, B. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501900200 · Cited by 584
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J. H., Weber, P. B., Feng, J. Q., Bonewald, L. F., & Kneissel, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01428-09 · Cited by 567
Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.997 · Cited by 561
Tsai, J. N., Uihlein, A. V., Lee, H., Kumbhani, R., Siwila-Sackman, E., McKay, E. A., Burnett-Bowie, S.-A. M., Neer, R. M., & Leder, B. Z. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60856-9 · Cited by 496
Lee, S.-K., & Lorenzo, J. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6887 · Cited by 464
Lrp5 functions in bone to regulate bone mass
Cui, Y., Niziolek, P. J., MacDonald, B. T., Zylstra, C. R., Alenina, N., Robinson, D. R., Zhong, Z., Matthes, S., Jacobsen, C. M., Conlon, R. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2388 · Cited by 453
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442
Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Greenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R., Zanchetta, J. R., Blosch, C. M., Mathisen, A. L., Morris, S. A., Marriott, T. B., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00005 · Cited by 427
Osteoblastic Cells Mediate Osteoclastic Responsiveness to Parathyroid Hormone*
McSHEEHY, P. M. J., & CHAMBERS, T. J. (1986) · Endocrinology · doi:10.1210/endo-118-2-824 · Cited by 407
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 390
PTH Differentially Regulates Expression of RANKL and OPG
Huang, J. C., Sakata, T., Pfleger, L. L., Bencsik, M., Halloran, B. P., Bikle, D. D., & Nissenson, R. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301226 · Cited by 382
Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307444200 · Cited by 378
Silverberg, S. J., Clarke, B. L., Peacock, M., Bandeira, F., Boutroy, S., Cusano, N. E., Dempster, D., Lewiecki, E. M., Liu, J.-M., Minisola, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1415 · Cited by 378
Self-citationKurland, E. S., Cosman, F., McMahon, D. J., Rosen, C. J., Lindsay, R., & Bilezikian, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6818 · Cited by 360
Self-citationGreenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R. S., Zanchetta, J., Blosch, C. M., Mathisen, A. L., Morris, S. A., & Marriott, T. B. (2007) · Annals of Internal Medicine · Cited by 360
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Parathyroid hormone: past and present
Potts, J. T. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06057 · Cited by 327
Dobnig, H. (1997) · Endocrinology · doi:10.1210/en.138.11.4607 · Cited by 322
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
Baron, R., & Hesse, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2332 · Cited by 320
Mirza, F. S., Padhi, I. D., Raisz, L. G., & Lorenzo, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2283 · Cited by 311
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
PTH and PTHrP signaling in osteoblasts
Datta, N. S., & Abou-Samra, A. B. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.012 · Cited by 295
Wronski, T. J. (1993) · Endocrinology · doi:10.1210/en.132.2.823 · Cited by 290
Osteocyte RANKL: New insights into the control of bone remodeling
Xiong, J., & O'Brien, C. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1547 · Cited by 287
Kurland, E. S. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3069 · Cited by 282
Lindsay, R., Cosman, F., Zhou, H., Bostrom, M. P., Shen, V. W., Cruz, J. D., Nieves, J. W., & Dempster, D. W. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051109 · Cited by 277
Kim, S. W., Pajevic, P. D., Selig, M., Barry, K. J., Yang, J.-Y., Shin, C. S., Baek, W.-Y., Kim, J.-E., & Kronenberg, H. M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1665 · Cited by 266
Calcium and phosphate homeostasis: Concerted interplay of new regulators
Renkema, K. Y., Alexander, R. T., Bindels, R. J., & Hoenderop, J. G. (2008) · Annals of Medicine · doi:10.1080/07853890701689645 · Cited by 263
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Drake, M. T., Srinivasan, B., Mödder, U. I., Peterson, J. M., McCready, L. K., Riggs, B. L., Dwyer, D., Stolina, M., Kostenuik, P., & Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0720 · Cited by 251
Osteocyte control of osteoclastogenesis
O'Brien, C. A., Nakashima, T., & Takayanagi, H. (2013) · Bone · doi:10.1016/j.bone.2012.08.121 · Cited by 235
Lindsay, R., Zhou, H., Cosman, F., Nieves, J., Dempster, D. W., & Hodsman, A. B. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070104 · Cited by 233
Li, X., Warmington, K. S., Niu, Q.-T., Asuncion, F. J., Barrero, M., Grisanti, M., Dwyer, D., Stouch, B., Thway, T. M., Stolina, M., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.182 · Cited by 231
Li, X., Qin, L., Bergenstock, M., Bevelock, L. M., Novack, D. V., & Partridge, N. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611781200 · Cited by 229
Ma, Y. L., Zeng, Q., Donley, D. W., Ste-Marie, L.-G., Gallagher, J. C., Dalsky, G. P., Marcus, R., & Eriksen, E. F. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060314 · Cited by 229
Fu, Q., Jilka, R. L., Manolagas, S. C., & O'Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 227
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations
Egbuna, O. I., & Brown, E. M. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.11.006 · Cited by 224
Guo, J., Liu, M., Yang, D., Bouxsein, M. L., Saito, H., Galvin, R. J. S., Kuhstoss, S. A., Thomas, C. C., Schipani, E., Baron, R., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.007 · Cited by 224
Effects of parathyroid hormone on Wnt signaling pathway in bone
Kulkarni, N. H., Halladay, D. L., Miles, R. R., Gilbert, L. M., Frolik, C. A., Galvin, R. J. S., Martin, T. J., Gillespie, M. T., & Onyia, J. E. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20506 · Cited by 224
Locklin, R. M., Khosla, S., Turner, R. T., & Riggs, B. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10490 · Cited by 219
Stein, E. M., Silva, B. C., Boutroy, S., Zhou, B., Wang, J., Udesky, J., Zhang, C., McMahon, D. J., Romano, M., Dworakowski, E., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1841 · Cited by 218
Self-citationPTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
Rhee, Y., Allen, M. R., Condon, K., Lezcano, V., Ronda, A. C., Galli, C., Olivos, N., Passeri, G., O'Brien, C. A., Bivi, N., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.304 · Cited by 208
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Powell, W. F., Barry, K. J., Tulum, I., Kobayashi, T., Harris, S. E., Bringhurst, F. R., & Divieti Pajevic, P. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0308 · Cited by 203
EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts
Allan, E. H., Häusler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S., Sims, N. A., Gillespie, M. T., Onyia, J. E., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080324 · Cited by 199
Effects of PTH on osteocyte function
Bellido, T., Saini, V., & Pajevic, P. D. (2013) · Bone · doi:10.1016/j.bone.2012.09.016 · Cited by 196
T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling
Terauchi, M., Li, J.-Y., Bedi, B., Baek, K.-H., Tawfeek, H., Galley, S., Gilbert, L., Nanes, M. S., Zayzafoon, M., Guldberg, R., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.010 · Cited by 193
Padhi, D., Allison, M., Kivitz, A. J., Gutierrez, M. J., Stouch, B., Wang, C., & Jang, G. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.239 · Cited by 185
Shen, V., Dempster, D. W., Birchman, R., Xu, R., & Lindsay, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116483 · Cited by 184
McColm, J., Hu, L., Womack, T., Tang, C. C., & Chiang, A. Y. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2092 · Cited by 173
Saini, V., Marengi, D. A., Barry, K. J., Fulzele, K. S., Heiden, E., Liu, X., Dedic, C., Maeda, A., Lotinun, S., Baron, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441360 · Cited by 167
Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling
Krishnan, V., Moore, T. L., Ma, Y. L., Helvering, L. M., Frolik, C. A., Valasek, K. M., Ducy, P., & Geiser, A. G. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0225 · Cited by 162
Skeletal actions of intermittent parathyroid hormone: Effects on bone remodelling and structure
Compston, J. E. (2007) · Bone · doi:10.1016/j.bone.2006.09.008 · Cited by 160
Kondo, H., Guo, J., & Bringhurst, F. R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.9.1667 · Cited by 158
Yu, B., Zhao, X., Yang, C., Crane, J. L., Xian, L., Lu, W. W., Wan, M., & Cao, X. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1663 · Cited by 149
The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells
Chambers, T. J., Fuller, K., McSheehy, P. M. J., & Pringle, J. A. S. (1985) · The Journal of Pathology · doi:10.1002/path.1711450403 · Cited by 148
Garnero, P., Sornay‐Rendu, E., Munoz, F., Borel, O., & Chapurlat, R. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1978-x · Cited by 144
Xiong, J., Piemontese, M., Thostenson, J. D., Weinstein, R. S., Manolagas, S. C., & O’Brien, C. A. (2014) · Bone · doi:10.1016/j.bone.2014.06.006 · Cited by 144
Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C. Y., & McCauley, L. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108913200 · Cited by 142
T Cells Potentiate PTH-Induced Cortical Bone Loss through CD40L Signaling
Gao, Y., Wu, X., Terauchi, M., Li, J., Grassi, F., Galley, S. A., Yang, X., Weitzmann, M. N., & Pacifici, R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.001 · Cited by 142
Fermor, B., & Skerry, T. M. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101213 · Cited by 133
Hansen, S., Jensen, J. B., Rasmussen, L. M., Hauge, E., & Brixen, K. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.98 · Cited by 132
Does osteocytic SOST suppression mediate PTH bone anabolism?
Krämer, I., Keller, H., Leupin, O., & Kneissel, M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.12.002 · Cited by 121
Leaffer, D., Sweeney, M., Kellerman, L., et al. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628402 · Cited by 116
Cells of the Osteoclast Lineage as Mediators of the Anabolic Actions of Parathyroid Hormone in Bone
Koh, A. J., Demiralp, B., Neiva, K. G., Hooten, J. N., Nohutçu, R. M., Shim, H., Datta, N. S., Taichman, R. S., & McCauley, L. K. (2005) · Endocrinology · doi:10.1210/en.2005-0333 · Cited by 114
Vilardaga, J., Frank, M., Krasel, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011495200 · Cited by 113
Onyia, J. E., Helvering, L. M., Gelbert, L. M., Wei, T., Huang, S., Chen, P., Dow, E. R., Maran, A., Zhang, M., Lotinun, S., et al. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20438 · Cited by 112
Lane, N. E., Sanchez, S., Genant, H. K., Jenkins, D. K., & Arnaud, C. D. (2000) · Osteoporosis International · doi:10.1007/s001980070111 · Cited by 109
Takyar, F. M., Tonna, S. J., Ho, P. W. M., Crimeen‐Irwin, B., Baker, E. K., Martin, T. J., & Sims, N. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1820 · Cited by 108
van Lierop, A. H., Witteveen, J. E., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0699 · Cited by 108
Bedi, B., Li, J., Tawfeek, H. A. W., Baek, K., Adams, J., Vangara, S. S., Chang, M.-K., Kneissel, M., Weitzmann, M. N., & Pacifici, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120735109 · Cited by 107
The cell biology of parathyroid hormone in osteoblasts
Kousteni, S., & Bilezikian, J. P. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0013-9 · Cited by 106
Self-citationOgita, M., Rached, M.-T., Dworakowski, E., Bilezikian, J. P., & Kousteni, S. (2008) · Endocrinology · doi:10.1210/en.2008-0369 · Cited by 103
Self-citationYang, D., Singh, R., Pajevic, P. D., Guo, J., Bouxsein, M., & Bringhurst, F. R. (2007) · Bone · doi:10.1016/j.bone.2007.02.001 · Cited by 100
Iahizuya, T. (1997) · Journal of Clinical Investigation · Cited by 100
RANKL subcellular trafficking and regulatory mechanisms in osteocytes
Honma, M., Ikebuchi, Y., Kariya, Y., Hayashi, M., Hayashi, N., Aoki, S., & Suzuki, H. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1941 · Cited by 98
Holdsworth, G., Slocombe, P. M., Doyle, C., Sweeney, B., Veverka, V., Riche, K. L., Franklin, R. J., Compson, J. E., Brookings, D. C., Turner, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350108 · Cited by 98
T cells: Critical bone regulators in health and disease
Pacifici, R. (2010) · Bone · doi:10.1016/j.bone.2010.04.611 · Cited by 98
Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
Tawfeek, H. A. W., Bedi, B., Li, J., Adams, J., Kobayashi, T., Weitzmann, M. N., Kronenberg, H. M., & Pacifici, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012290 · Cited by 95
Hisa, I., Inoue, Y., Hendy, G. N., Canaff, L., Kitazawa, R., Kitazawa, S., Komori, T., Sugimoto, T., Seino, S., & Kaji, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179127 · Cited by 87
Parathyroid Hormone as an Anabolic Skeletal Therapy
Rubin, M. R., & Bilezikian, J. P. (2005) · Drugs · doi:10.2165/00003495-200565170-00005 · Cited by 82
Self-citationChang, M.-K., Krämer, I., Keller, H., Gooi, J. H., Collett, C., Jenkins, D., Ettenberg, S. A., Cong, F., Halleux, C. M., & Kneissel, M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2059 · Cited by 77
The role of visfatin in the pathogenesis of gestational diabetes mellitus
Gök, D. E., Yazıcı, M., Üçkaya, G., Bolu, Ş. E., Başaran, Y., Ozgurtas, T., Kiliç, S., & Kutlu, M. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346687 · Cited by 75
Sclerostin: Therapeutic Horizons Based Upon Its Actions
Costa, A. G., & Bilezikian, J. P. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0089-5 · Cited by 73
Self-citationLi, J., Walker, L. D., Tyagi, A. M., Adams, J., Weitzmann, M. N., & Pacifici, R. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2044 · Cited by 72
Wang, Y., Liu, Y., & Rowe, D. W. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00216.2006 · Cited by 72
Ardawi, M. S., Al-Sibiany, A., Bakhsh, T. M., Rouzi, A. A., & Qari, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1806-8 · Cited by 69
Kanzawa, M., Sugimoto, T., Kanatani, M., & Chihara, K. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420661 · Cited by 68
Anastasilakis, A. D., Pοlyzos, S. A., Avramidis, A., Toulis, K. A., Παπαθεοδώρου, Α., & Terpos, E. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03728.x · Cited by 67
Sclerostin and DKK1 in Primary Hyperparathyroidism
Viapiana, O., Fracassi, E., Troplini, S., Idolazzi, L., Rossini, M., Adami, S., & Gatti, D. (2013) · Calcified Tissue International · doi:10.1007/s00223-012-9665-7 · Cited by 67
Yao, G., Wu, J.-J., Troiano, N. W., & Insogna, K. L. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0202-3 · Cited by 65
Acute Decline in Serum Sclerostin in Response to PTH Infusion in Healthy Men
Yu, E. W.-Y., Kumbhani, R., Siwila-Sackman, E., & Leder, B. Z. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1534 · Cited by 61
Tamasi, J. A., Vasilov, A., Shimizu, E., Benton, N. A., Johnson, J., Bitel, C. L., Morrison, N. A., & Partridge, N. C. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1933 · Cited by 59
Rhee, Y., Lee, E.-Y., Lezcano, V., Ronda, A. C., Condon, K. W., Allen, M. R., Plotkin, L. I., & Bellido, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485938 · Cited by 55
Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair
Schnoke, M., Midura, S. B., & Midura, R. J. (2009) · Bone · doi:10.1016/j.bone.2009.05.006 · Cited by 53
Stilgren, L. S., Rettmer, E., Eriksen, E. F., Hegedűs, L. D., Beck‐Nielsen, H., & Abrahamsen, B. (2004) · Bone · doi:10.1016/j.bone.2004.03.012 · Cited by 52
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease
Mason, J. J., & Williams, B. O. (2010) · Journal of Osteoporosis · doi:10.4061/2010/460120 · Cited by 47
Nakchbandi, I. A., Lang, R., Kinder, B. K., & Insogna, K. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1645 · Cited by 47
Role of T cells in the modulation of PTH action: physiological and clinical significance
Pacifici, R. (2013) · Endocrine · doi:10.1007/s12020-013-9960-8 · Cited by 44
Lrp5 regulation of bone mass and serotonin synthesis in the gut
Kode, A., Obri, A., Paone, R., Kousteni, S., Ducy, P. F., & Karsenty, G. (2014) · Nature Medicine · doi:10.1038/nm.3698 · Cited by 34
Gαq Signal in Osteoblasts Is Inhibitory to the Osteoanabolic Action of Parathyroid Hormone
Ogata, N., Shinoda, Y., Wettschureck, N., Offermanns, S., Takeda, S., Nakamura, K., Segre, G. V., Chung, U., & Kawaguchi, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200196 · Cited by 26
Pharmacological Mechanisms of Therapeutics
Hanley, D. A., Watson, P. H., Hodsman, A. B., & Dempster, D. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00085-9 · Cited by 21
Patel, H. H., Trooskin, S. Z., Shapses, S. A., Sun, W. C., & Wang, X. (2014) · Endocrine Practice · doi:10.4158/ep14104.or · Cited by 19
Cellular Actions of Parathyroid Hormone
Kousteni, S., & Bilezikian, J. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00049-5 · Cited by 19
Self-citationCell Cycle and Apoptosis Regulatory Protein (CARP)-1 is Expressed inOsteoblasts and Regulated by PTH
Sharma, S., Mahalingam, C. D., Das, V., Jamal, S., Levi, E., Rishi, A. K., & Datta, N. S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.136 · Cited by 14
Molecular Actions of Parathyroid Hormone
Revollo, L., & Civitelli, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00007-2 · Cited by 6
Cited by
Osteoblast-Osteoclast Communication and Bone Homeostasis
Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H. (2020) · Cells · doi:10.3390/cells9092073 · Cited by 1,178
Kenkre, J., & Bassett, J. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563218759371 · Cited by 693
Wu, Y., Xie, L., Wang, M., Xiong, Q., Guo, Y., Liang, Y., Li, J., Sheng, R., Deng, P., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06898-4 · Cited by 430
Khundmiri, S. J., Murray, R. D., & Lederer, E. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c140071 · Cited by 296
The role of vitamin D in the endocrinology controlling calcium homeostasis
Fleet, J. C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.008 · Cited by 296
Metadata
- Authors
- Silva, B. C., & Bilezikian, J. P.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 22
- Pages
- 41-50
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2083068026
- Cited by
- 557
- References
- 133
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.